Low platelets and bleeding risk on T-DM1

Platelets are small blood cells that help your blood clot when you bleed. T-DM1, also known as trastuzumab emtansine or Kadcyla, often lowers the platelet count. This is one of its most common effects on blood tests. It happens because the chemotherapy part of the medicine, called DM1, affects the cells in the bone marrow that make platelets. The count typically falls to its lowest point about a week after a dose and then recovers before the next cycle is due. For most people the drop is mild to moderate and causes nothing more than easier bruising or the occasional nosebleed. In some people the fall is larger, and a small number have serious bleeding, which is why platelets are checked before every dose. Research suggests low platelets may be more common in people of Asian background, so this is watched especially closely in India. If your count is too low on the day of treatment, your team will usually delay the dose until it recovers, and may lower the dose afterwards. Taking blood thinners, aspirin or anti-inflammatory painkillers adds to bleeding risk, so tell your team about any of these. You can also help by knowing the warning signs of bleeding and taking simple precautions at home. Most people who have low platelets on T-DM1 are able to continue treatment with these adjustments.

Usually a predictable dip

Platelets tend to fall in the first week or so after a dose and recover by the next one.

Checked before every dose

A blood count on or just before treatment day decides whether the dose goes ahead.

Bleeding signs need attention

Most bruising is minor, but some bleeding needs urgent care, so know the signs.

Platelet changes on T-DM1 are well understood in general, but individual patterns vary a great deal.

Serious bleeding is uncommon but real

Most bleeding is minor. Rarely, serious bleeding has happened, sometimes even when the count was not very low, so warning signs should never be ignored.

Some people have a slow downward trend

In some people the count does not fully recover between doses and drifts lower over several cycles. This may lead to dose reductions or a change of treatment.

Other causes are possible

Low platelets can also come from other medicines, infections, liver problems or cancer in the bone marrow, so your team may look further.

What this page cannot tell you

It cannot tell you what count is safe for your next dose. Your team decides that using your results and your overall health.

Nosebleeds are among the most common bleeding effects on T-DM1. Most are short and settle with simple first aid, but it helps to know what to do.

First aid

Sit upright and lean slightly forward. Pinch the soft part of your nose firmly and breathe through your mouth for at least ten minutes without letting go. Do not tip your head back.

Prevention

Dry air can make nosebleeds more likely. A saline nasal spray or gel may help, and blowing your nose gently avoids breaking small vessels.

When to get help

Seek urgent help if bleeding continues despite firm pressure, if it is very heavy, or if you feel faint. Tell your team about frequent nosebleeds even when they stop.